Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ikervis for Prophylaxis of Dry Eye Disease Due to Graft vs Host Disease Post Allogeneic Haemtopoietic Stem Cell Transplant

NCT04636918 is registered in ClinicalTrials.gov with Singapore Eye Research Institute as lead sponsor.

NCT NCT04636918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04636918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ikervis for Prophylaxis of Dry Eye Disease Due to Graft vs Host Disease Post Allogeneic Haemtopoietic Stem Cell Transplant
Lead sponsor
Singapore Eye Research Institute
Phase
Phase 4
Overall status
Unknown status
Start date
November 28, 2019
Completion date
December 30, 2022
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia (both all and aml), mds-eb-1